We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drug Industry: Transparency Requires Global Reporting Processes
Drug Industry: Transparency Requires Global Reporting Processes
February 21, 2013
Drugmakers working to comply with the recently released Physician Payments Sunshine Act rule, along with transparency legislation around the world, should create internal reporting systems that satisfy all of these requirements, industry experts say.